Brief: Dianthus Therapeutics Files For Resale Of Up To 23.7 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
01/10/2024 22:12
Dianthus Therapeutics Inc DNTH.O :
* DIANTHUS THERAPEUTICS FILES FOR RESALE OF UP TO 23.7
MILLION
SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING
Source text for Eikon: ID:n0001193125-24-230212
Further company coverage: DNTH.O
Recent news on Dianthus Therapeutics
See all newsU.S. RESEARCH ROUNDUP- Adobe, Chewy, Mosaic
Brief: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
Dianthus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dianthus Therapeutics Q2 net loss widens as R&D costs rise